Literature DB >> 30815046

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).

Akira Baba1,2, Hiroya Ojiri1, Tazuko K Goto3, Koshi Ikeda1, Hideomi Yamauchi1, Nobuhiro Ogino4, Takuji Mogami2.   

Abstract

Generally, CT and MR images of antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) show nonspecific findings as seen in active osteomyelitis.However, there are some characteristics as follows; unilateral maxillary sinusitis adjacent to ipsilateral maxillary ARONJ/MRONJ, DRONJ presenting larger sequestrum and periosteal reaction more frequently than BRONJ, BRONJ resulting from intravenous administration of the drug presenting larger and more frequent buccolingual cortical bone perforations than BRONJ from oral administration, and better diagnostic accuracy of extent of perilesional soft tissue inflammation on MR imaging than CT. The CT and MR imaging features of ARONJ/MRONJ are summarized in this report.

Entities:  

Keywords:  Antiresorptive agent-related osteonecrosis of the jaw; Bisphosphonate; CT; Denosumab; MR imaging; Medication-related osteonecrosis of the jaw

Year:  2019        PMID: 30815046      PMCID: PMC6378898          DOI: 10.1016/j.jdsr.2018.11.001

Source DB:  PubMed          Journal:  Jpn Dent Sci Rev        ISSN: 1882-7616


Introducttion

Medication-related osteonecrosis of the jaw (MRONJ) is defined as a complication associated with antiresorptive medications and antiangiogenic medications by American Association of Oral and Maxillofacial Surgeons (AAOMS) [1]. This entity is corresponded to antiresorptive agent-related osteonecrosis of the jaws (ARONJ) defined by position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw in Japan [2]. ARONJ/MRONJ includes bisphosphonate-related osteonecrosis of the jaw (BRONJ) and denosumab-related osteonecrosis of the jaw (DRONJ). The MRONJ staging system recommended by AAOMS assigns patients to different stages based only on clinical manifestations not including radiological evaluation [1]. Nevertheless the clinical examination cannot usually reveal the disease extent and involvement of ARONJ/MRONJ beneath the mucosa [3], [4]. In clinical practice, CT and MR imaging are used for the purpose of the evaluation of lesion extents and activity. The CT and MR imaging features of ARONJ/MRONJ are summarized in this report.

CT

Usefulness

CT is one of the imaging modalities for evaluation of ARONJ/MRONJ. It has a great advantage of morphological evaluation and delineating the extent of this disease [4], [5]. CT tends to be chosen secondary to panoramic radiography (PR) in clinical practice. It has been reported that the detectability of ARONJ/MRONJ is 96% in CT compared with 54% in PR [6]. Besides the high sensitivity, CT offers greater information on the extent of bone involvement with better precision than PR for observation of the ARONJ/MRONJ [4], [7]. PR serves as the baseline imaging and possibly depicts signs that may serve as predictors for the disease extent including sclerosis, thickening of the lamina dura, prominent mandibular canal, and delayed healing of extraction sockets [7], [8]. CT shows higher sensitivity than PR, particularly with regard to soft tissue swelling, periosteal bone reaction, and sequestrum as previously reported [6], [8], [9], [10].

Location

The mandibular ARONJ/MRONJ was the most frequently presented site (95%) [11]. In the study we reported, the mandibular ARONJ/MRONJ was also detected more frequently than maxillary ARONJ/MRONJ (78.7% vs 21.3%) [12]. When including all mandibular and maxillary ARONJ/MRONJ, posterior parts of the jaws were the more involved more (86%) than anterior [12]. There was no location laterality in ARONJ/MRONJ [12].

CT imaging findings

In general, CT findings of ARONJ/MRONJ are not specific and can also be similar to ordinary osteomyelitis of the jaw. Previous studies reported that the CT evaluation for ARONJ/MRONJ showed lytic and/or sclerotic lesion, periosteal reaction, cortical perforation, periosteal reaction, mandibular fractures, and soft tissue inflammation [7], [9], [10], [13], [14] (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6, Fig. 7, Fig. 8). In a previous study, the presence of expansive lytic lesions with a dense sequestrum resulting in a bone-within-bone appearance has been reported as the characteristic image finding [14] (Fig. 4).
Fig. 1

A woman in her 70 s diagnosed as BRONJ.

On axial and coronal CT in bone window setting (Fig. 1A, B), sclerotic and lytic lesion with buccal and lingual cortical bone perforation (arrows), periosteal reaction (arrowheads) and sequestrum (S) were detected in the left body of the mandible. On axial CT in soft tissue window setting (Fig. 1C), soft tissue thickening adjacent to the lesion was detected. The lesion was identified as low signal intensity on axial T1-weighted imaging (Fig. 1D) and high signal intensity on STIR MR imaging (Fig. 1E). STIR MR imaging also revealed edematous high signal intensity in adjacent soft tissue which indicates presence of active inflammation.

Fig. 2

A man in his 60 s diagnosed as BRONJ.

On axial CT in bone window setting (Fig. 2A), sclerotic and lytic lesion with buccal and lingual cortical bone perforation (arrows) and periosteal reaction (arrowhead) were detected in the right body of the mandible. On axial CT in soft tissue window setting (Fig. 2B), soft tissue thickening was detected (arrows). The right body of the mandible was low signal intensity on axial T1-weighted imaging (Fig. 2C) and high signal intensity on STIR MR imaging (Fig. 2D). STIR MR imaging also revealed edematous high signal intensity in soft tissue adjacent to the lesion which indicates presence of active inflammation.

Fig. 3

A woman in her 60 s diagnosed as BRONJ.

On axial CT in bone window setting (Fig. 3A) revealed sclerotic changes with cystic low density lesion in the right body of the mandible. A high density structure with ill-defined margin (S) in the cystic low density area was considered as sequestrum formation. T2-weighted imaging (Fig. 3B) revealed high signal intensity cystic area without detectable sequestrum.

Fig. 4

A woman in her 50 s diagnosed as BRONJ.

On axial and coronal CT images in bone window setting (Fig. 4A, B), expansive lytic lesion with a dense (arrows) sequestrum resulting in a “bone-within-bone appearance” was detected in the left body of the mandible.

Fig. 5

A woman in her 70 s diagnosed as BRONJ.

On coronal CT in bone window setting demonstrated sclerotic/lytic changes and squestrum (arrow) of left maxilla. These findings were compatible with BRONJ. Left unilateral maxillary sinusitis (M) adjacent to the left maxillary BRONJ lesion was detected. This sinusitis was expected to result from ARONJ/MRONJ of maxilla.

Fig. 6

A woman in her 60 s diagnosed as BRONJ resulting from intravenous bisphosphonate administration.

On axial coronal CT in bone window setting (Fig. 6A, B), buccal and lingual cortical bone perforation (arrows) of right mandible were identified.

Fig. 7

A woman in her 70 s diagnosed as DRONJ.

On axial coronal CT in bone window setting (Fig. 7A, B), periosteal reaction (arrows) along both buccal and lingual cortices was detected.

Fig. 8

A man in his 70 s diagnosed as DRONJ.

On axial and parasagittal CT in bone window setting (Fig. 8A, B), relatively large (2.8 cm) sequestrum (arrows) was noted in the left body of mandible.

A woman in her 70 s diagnosed as BRONJ. On axial and coronal CT in bone window setting (Fig. 1A, B), sclerotic and lytic lesion with buccal and lingual cortical bone perforation (arrows), periosteal reaction (arrowheads) and sequestrum (S) were detected in the left body of the mandible. On axial CT in soft tissue window setting (Fig. 1C), soft tissue thickening adjacent to the lesion was detected. The lesion was identified as low signal intensity on axial T1-weighted imaging (Fig. 1D) and high signal intensity on STIR MR imaging (Fig. 1E). STIR MR imaging also revealed edematous high signal intensity in adjacent soft tissue which indicates presence of active inflammation. A man in his 60 s diagnosed as BRONJ. On axial CT in bone window setting (Fig. 2A), sclerotic and lytic lesion with buccal and lingual cortical bone perforation (arrows) and periosteal reaction (arrowhead) were detected in the right body of the mandible. On axial CT in soft tissue window setting (Fig. 2B), soft tissue thickening was detected (arrows). The right body of the mandible was low signal intensity on axial T1-weighted imaging (Fig. 2C) and high signal intensity on STIR MR imaging (Fig. 2D). STIR MR imaging also revealed edematous high signal intensity in soft tissue adjacent to the lesion which indicates presence of active inflammation. A woman in her 60 s diagnosed as BRONJ. On axial CT in bone window setting (Fig. 3A) revealed sclerotic changes with cystic low density lesion in the right body of the mandible. A high density structure with ill-defined margin (S) in the cystic low density area was considered as sequestrum formation. T2-weighted imaging (Fig. 3B) revealed high signal intensity cystic area without detectable sequestrum. A woman in her 50 s diagnosed as BRONJ. On axial and coronal CT images in bone window setting (Fig. 4A, B), expansive lytic lesion with a dense (arrows) sequestrum resulting in a “bone-within-bone appearance” was detected in the left body of the mandible. A woman in her 70 s diagnosed as BRONJ. On coronal CT in bone window setting demonstrated sclerotic/lytic changes and squestrum (arrow) of left maxilla. These findings were compatible with BRONJ. Left unilateral maxillary sinusitis (M) adjacent to the left maxillary BRONJ lesion was detected. This sinusitis was expected to result from ARONJ/MRONJ of maxilla. A woman in her 60 s diagnosed as BRONJ resulting from intravenous bisphosphonate administration. On axial coronal CT in bone window setting (Fig. 6A, B), buccal and lingual cortical bone perforation (arrows) of right mandible were identified. A woman in her 70 s diagnosed as DRONJ. On axial coronal CT in bone window setting (Fig. 7A, B), periosteal reaction (arrows) along both buccal and lingual cortices was detected. A man in his 70 s diagnosed as DRONJ. On axial and parasagittal CT in bone window setting (Fig. 8A, B), relatively large (2.8 cm) sequestrum (arrows) was noted in the left body of mandible. A woman in her 70 s diagnosed as BRONJ. On axial CT in bone window setting (Fig. 9A), no focal abnormality was detected in the left body of mandible. STIR MR imaging (Fig. 9B) revealed high signal intensity in the left body of mandible, which was compatible with ARONJ/MRONJ.
Fig. 9

A woman in her 70 s diagnosed as BRONJ.

On axial CT in bone window setting (Fig. 9A), no focal abnormality was detected in the left body of mandible. STIR MR imaging (Fig. 9B) revealed high signal intensity in the left body of mandible, which was compatible with ARONJ/MRONJ.

It was reported that ARONJ/MRONJ tends to show thicker cortical bones, more sclerotic bone marrow [15], [16], [17], and narrower neurovascular canals including nasopalatine and mandibular canal [17] in the studies with assessment using cone beam CT (CBCT). CT findings of patients with ARONJ/MRONJ in our study [12] are presented in Table 1. The internal texture of ARONJ/MRONJ were mainly mixture of lytic and sclerotic type (61.3%) (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6, Fig. 7). Sequestrum was seen in about a half (52%) of the cases (Figs. 1, 3–6, 8). Swelling of soft tissue including gingiva was detected in relatively high frequency (81.3%) on CT (Figs. 1, 2). Periosteal reactions adjacent to ARONJ/MRONJ were detected in relatively low frequency (17.3%) (Figs. 2, 7). Cortical perforation was detected in more than half of the cases (57.3%) (Figs. 1, 2, 6). The frequency of cortical perforation at both buccal and lingual aspects (51.2%) (Figs. 1, 2, 6) was slightly greater than that of buccal aspects only (39.5%), while that of lingual one was only 9.3%. Bone expansions were detected in one third (33.3%) (Fig. 4). Pathological fractures were uncommon, presenting in only 5.3%. ARONJ/MRONJ of the maxilla adjacent to the maxillary sinus is known to show mucoperiosteal thickening, air-fluid levels, and fistula formation [4], [10], [18]. Similar to those reports, all patients of upper ARONJ/MRONJ (100%) in our study showed maxillary sinusitis on the same side [12].
Table 1

CT Findings of patients with ARONJ/MRONJ (N = 74, 75 jaws).

Location
 Maxilla16 (21.3)



 Mandible59 (78.7)
 Anterior8 (10.7)
 Posterior63 (84.0)
 Whole4 (5.3)



 Right32 (42.7)
 Left35 (46.7)
 Bilateral8 (10.6)



Internal texture
 Normal3 (4.0)
 Sclerotic26 (34.7)
 Lytic and sclerotic46 (61.3)



Sequestrum
 Present39 (52.0)
 Absent36 (48.0)



Sequestrum size
 Large (>20 mm)6 (15.4)
 Small (<20 mm)33 (84.6)



Periosteal reaction
 Present11 (14.7)
 Absent64 (85.3)



Cortical perforation
 Present43 (57.3)
 Absent32 (42.7)



 Buccal17 (39.5)
 Lingual4 (9.3)
 Buccal and lingual22 (51.2)



Soft tissue swelling
 Present60 (80.0)
 Absent15 (20.0)



Bone expansion
 Present25 (33.7)
 Absent50 (66.7)



Pathological fracture
 Present4 (5.3)
 Absent71 (94.7)



Unilateral maxillary sinusitis adjacent to upper MRONJ
 Present16 (100)
 Absent0

Note. — Data are number of findings, percentages.

CT Findings of patients with ARONJ/MRONJ (N = 74, 75 jaws). Note. — Data are number of findings, percentages.

Comparison between BRONJ and DRONJ

DRONJ showed larger sequestrum and periosteal reaction more frequently than BRONJ in our study [12] (Figs. 7, 8). Underlying pathophysiological mechanisms of these phenomena are still uncertain. There has been a report that DRONJ tended to be detected in higher stage [19] which may be related to the sequestrum size. Difference of sequestrum formation between DRONJ and BRONJ might be affected by separation speed of bony sequestrum. Considering different periosteal reactions between DRONJ and BRONJ, drug distributions and pharmacokinetics might have some influences on the jaws in relative mechanisms. Although denosumab, compared with bisphosphonate, has significantly greater reductions in bone turnover markers, it does not accumulate on bones. It also has shorter half-life, rapid offset of action and reversibility of its antiresorptive effect, and displays low-cytotoxicity or antiangiogenic profiles [20], [21], [22], [23]. In addition, Denosumab primarily inhibits remodeling-based bone formation and permits modeling-based bone formation whereas bisphosphonate tends to cease both pathways [24]. These differences may make DRONJ more prone to advanced separation of necrotic bones from surrounding bony tissue and periosteal expansion. The CT findings of large sequestrum and periosteal reaction would be a characteristic for DRONJ.

Comparison between BRONJ resulting from oral bisphosphonate administration and intravenous administration

The patients of BRONJ resulting from intravenous bisphosphonate administration showed larger and more frequent buccolingual cortical bone perforations than BRONJ resulting from oral bisphosphonate administration in our study [12] (Fig. 6). Cortical perforation was detected in about half of the cases (47%) in the the patients of BRONJ resulting from intravenous bisphosphonate administration. The lesions were mostly presented both buccal and lingual cortical perforation (87%) [12]. Previous studies showed higher incidence rates of BRONJ with intravenous administration than with oral administration [5], [11], [25], [26]. Based on previous reports as well as our study, BRONJ resulting from intravenous bisphosphonate tended to show more progressive disease compared to those with oral bisphosphonate. The CT findings of buccolingual cortical perforation would be a characteristic for BRONJ with intravenous administration.

Imaging features of BRONJ among different clinical stages

When focusing on relationship between radiological findings and clinical stages, studies in the past describe some correlations. One report said that stage 0 and stage 1 BRONJ patients tended to show osseous sclerosis, stage 2 patients periosteal reaction and cortical bone perforation, and stage 3 patients mandibular fractures in addition to all other findings [7]. It has also been described that early-stage BRONJ may present predominantly osteolytic change with cortical bone destruction [13]. On the other hand, advanced BRONJ may present with increased bone density, periosteal reactions, and bone sequestrations [4], [10]. However, according to our study, there were no statistically significant differences among stage 0, 1 and 2, 3 nor between 0 –2 and 3 in patients with BRONJ [12]. Compared to our study, the size of the previous studies were rather small and no statistical evaluation was performed [4], [10], [13]. This discrepancy suggests that there probably are only weak relationship between specific CT findings and BRONJ clinical stage.

Comparison among medications in BRONJ

Hydroxyapatite (HAP) adsorption affinity is different for bisphosphonate medications such as alendronate, zoledronate, risedronate and minodronate [27]. It is likely that differences in HAP adsorption affinity influence imaging findings, however, according to our study, no significant statistical differences of CT findings along different BRONJ medications were observed [12].

Comparison between BRONJ with long-term administration and short-term administration

Although BRONJ was more prevalent in patients who were under longer medication duration [2], there were no statistically significant differences between BRONJ with long-term (more than 4 years) administration and short-term (less than 4 years) administration [12].

MR imaging

MR imaging provides supportive information a diagnosis and accurate disease extent in ARONJ/MRONJ. Occasionally, MR imaging reveal ARONJ/MRONJ lesion which is undetectable on CT. As well as evaluation for ordinary osteomyelitis of the jaw, MR sequence, such as short-tau inversion recovery (STIR), can assess the activity of the disease by detecting bone marrow edema. Although the detectability of ARONJ/MRONJ in MR imaging is superior to that in PR [28], it was reported that the detectability of ARONJ/MRONJ is 96% in CT superior to 92% in MR imaging [6]. Particularly, the detectability of sequestrum, cortical bone perforation and periosteal reaction on MR imaging is expected to be inferior to that on CT.

MR imaging findings

A few reports stated that MR imaging findings of ARONJ/MRONJ is nonspecific as seen in active osteomyelitis [29], [30]. Findings of patients with ARONJ/MRONJ of MR imaging in our study [31] are presented in Table 2. The signal intensity on T2-weighted imaging was mainly low or intermediate (73%) rather than high (27%). The signal intensity on T1-weighted imaging was mostly low (94%) (Figs. 1D, 2C). All ARONJ/MRONJ lesions presented high signal intensity on STIR MR imaging (100%) (Figs. 1E, 2D). Soft tissue swelling was detected in almost all lesions (94%) (Figs. 1, 2). Such MR imaging features are compatible with ordinary osteomyelitis of the jaw. This is consistent with previous reports that early-stage ARONJ/MRONJ may present high signal intensity on T2-weighted imaging and low signal intensity on T1 weighed imaging, and advanced ARONJ/MRONJ may present low signal intensity on T2-weighted imaging and T1 weighed imaging [29]. The detectability of soft tissue swelling is 94% on MR imaging compared with 80% on CT [12]. Higher contrast resolution of MR imaging compared with CT might have influences on this result. In our study, there was no significant correlation among MR imaging findings, and method of administration (oral or intravenous), term of administration (shot or long), and clinical stages of BRONJ.
Table 2

MR imaging Findings of patients with ARONJ/MRONJ (N = 33, 34 jaws).

T2-weighted imaging
 Low15 (44)
 Intermediate10 (29)
 High9 (27)



T1-weighted imaging
 Low32 (94)
 Intermediate2 (6)



STIR
 High34 (100)



Swelling of soft tissue
 Present32 (94)
 Absent2 (6)

Note.— Data are number of findings, percentages.

MR imaging Findings of patients with ARONJ/MRONJ (N = 33, 34 jaws). Note.— Data are number of findings, percentages.

Conclusions

CT and MR imaging are often need as imaging modalities in assessment of ARONJ/MRONJ. CT is considered as a standard one and evaluation in MR imaging is complementary. CT imaging findings of ARONJ/MRONJ are identified as ordinary osteomyelitis of the jaw. In our retrospective review, DRONJ tends to showed large sequestrum and periosteal reaction and BRONJ resulting from intravenous bisphosphonate administration tends to show buccolingual cortical bone perforations. All patients of upper ARONJ/MRONJ in our study showed maxillary sinusitis on the same side. MR imaging findings of ARONJ/MRONJ is identified as active osteomyelitis of the jaw. Adjacent soft tissue swelling could be evaluate more precisely than CT.

Funding

There were no sources of funding.

Conflict of interest

The authors declare that there is no conflict of interest.
  30 in total

Review 1.  Medication-Related Osteonecrosis of the Jaw: Basic and Translational Science Updates.

Authors:  Matthew R Allen
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-08-13       Impact factor: 2.802

2.  Bone-within-bone appearance: a red flag for biphosphonate-associated osteonecrosis of the jaw.

Authors:  Girish M Fatterpekar; Julius Valentin Emmrich; Jean Anderson Eloy; Amit Aggarwal
Journal:  J Comput Assist Tomogr       Date:  2011 Sep-Oct       Impact factor: 1.826

3.  Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Frank Wilde; Marcus Heufelder; Kai Lorenz; Susanne Liese; Jan Liese; Jens Helmrich; Alexander Schramm; Alexander Hemprich; Edgar Hirsch; Karsten Winter
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12

4.  Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography.

Authors:  Yuxing Guo; Diancan Wang; Yang Wang; Xin Peng; Chuanbin Guo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-04-22

5.  CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

Authors:  Akira Baba; Tazuko K Goto; Hiroya Ojiri; Mutsumi Takagiwa; Chiho Hiraga; Masahiro Okamura; Sho Hasegawa; Yumi Okuyama; Nobuhiro Ogino; Hideomi Yamauchi; Yuko Kobashi; Shinji Yamazoe; Yohei Munetomo; Takuji Mogami; Takeshi Nomura
Journal:  Dentomaxillofac Radiol       Date:  2018-02-13       Impact factor: 2.419

Review 6.  Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Toshihiko Nagata; Masahiro Urade; Takahiko Shibahara; Satoru Toyosawa
Journal:  J Bone Miner Metab       Date:  2016-12-29       Impact factor: 2.626

7.  Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

Authors:  Noopur Raje; Sook-Bin Woo; Karen Hande; Jeffrey T Yap; Paul G Richardson; Sonia Vallet; Nathaniel Treister; Teru Hideshima; Niall Sheehy; Shweta Chhetri; Brendan Connell; Wanling Xie; Yu-Tzu Tai; Agnieszka Szot-Barnes; Mei Tian; Robert L Schlossman; Edie Weller; Nikhil C Munshi; Annick D Van Den Abbeele; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2008-04-15       Impact factor: 12.531

8.  Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.

Authors:  Anant Krishnan; Atilla Arslanoglu; Nadir Yildirm; Richard Silbergleit; Nafi Aygun
Journal:  J Comput Assist Tomogr       Date:  2009 Mar-Apr       Impact factor: 1.826

9.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

Review 10.  Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).

Authors:  Akira Baba; Hiroya Ojiri; Tazuko K Goto; Koshi Ikeda; Hideomi Yamauchi; Nobuhiro Ogino; Takuji Mogami
Journal:  Jpn Dent Sci Rev       Date:  2019-02-15
View more
  2 in total

1.  Osteonecrosis of the jaws associated with denosumab: Study of clinical and radiographic characteristics in a series of clinical cases.

Authors:  Victoria I Tofé; Leticia Bagán; José V Bagán
Journal:  J Clin Exp Dent       Date:  2020-07-01

Review 2.  Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).

Authors:  Akira Baba; Hiroya Ojiri; Tazuko K Goto; Koshi Ikeda; Hideomi Yamauchi; Nobuhiro Ogino; Takuji Mogami
Journal:  Jpn Dent Sci Rev       Date:  2019-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.